Medical Dosimetry
Volume 33, Issue 3 , Pages 169-174, Autumn 2008

Effect of Contrast Media on Megavoltage Photon Beam Dosimetry

Presented at the combined Australian Institute of Radiography/New Zealand Institute of Medical Radiation Technology 2005 Conference, Auckland, New Zealand, August 26–28, 2005.

  • Ashley W. Rankine, B.App. Sc.

      Affiliations

    • Corresponding Author InformationReprint requests to: Mr. Ashley Rankine, B.App. Sc., Department of Radiation Oncology, Sir Charles Gairdner Hospital, Verdun Street, Nedlands, Perth, WA 6009, Australia.
  • ,
  • Peter J. Lanzon, B.Sc. (Hons), M.Sc.
  • ,
  • Nigel A. Spry, M.B.B.S., F.R.C.P., F.R.C.R., F.R.A.N.Z.C.R., F.A.Ch.P.M.

Department of Radiation Oncology, Sir Charles Gairdner Hospital, Verdun Street, Nedlands, Perth, WA 6009, Australia

Received 27 July 2006; accepted 16 April 2007. published online 22 November 2007.

Abstract 

The purpose of this study was to quantify changes in photon beam dosimetry caused by using contrast media during computed tomography (CT) simulation and determine if the resulting changes are clinically significant. The effect of contrast on dosimetry was first examined for a single 6-MV photon beam incident on a plane phantom with a structure of varying electron densities (ρe) and thickness. Patient studies were then undertaken in which CT data sets were collected with and without contrast for 6 typical patients. Three patients received IV contrast (Optiray-240™) only and 3 received IV plus oral (Gastrograffin™) contrast. Each patient was planned using conformal multifield techniques in accordance with the department standards. Two methods were used to compare the effect of contrast on dosimetry for each patient. The phantom analysis showed that the change in dose at the isocenter for a single 10 × 10 cm2 6-MV photon beam traversing 10 cm of a contrast-enhanced structure with ρe 1.22 was 7.0% (1.22 was the highest average ρe observed in the patient data). As a result of using contrast, increases in ρe were observed in structures for the 6 patients studied. Consequently, when using contrast-enhanced CT data for multifield planning, increases in dose at the isocenter and in critical structures were observed up to 2.1% and 2.5%, respectively. Planning on contrast-enhanced CT images may result in an increase in dose of up to 2.1% at the isocenter, which would generally be regarded as clinically insignificant. If, however, a critical organ is in close proximity to the planning target volume (PTV) and is planned to receive its maximum allowable dose, planning on contrast-enhanced CT images may result in that organ receiving dose beyond the recommended tolerance. In these instances, pre-contrast CT data should be used for dosimetry.

Key Words: Radiotherapy, CT, Contrast, Dosimetry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0958-3947(07)00084-2

doi:10.1016/j.meddos.2007.04.007

Medical Dosimetry
Volume 33, Issue 3 , Pages 169-174, Autumn 2008